Predictive Model on the Effect of Lifestyles in the Management of T2D
NCT ID: NCT05261841
Last Updated: 2023-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2021-06-26
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Brief Lifestyle Intervention in Type 2 Diabetes, Compared With a Longer Group Educational Program
NCT03579420
Lifestyle Intervention in Individuals With Low or High Genetic Risk for Type 2 Diabetes
NCT02709057
Change of Lifestyle by Persons in Risk of Type 2 Diabetes
NCT00202748
Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs
NCT05056376
Computer-assisted Diabetes Self-management Interventions
NCT00006163
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TYPE 2 DIABETES
Patients affected by type 2 diabetes
Standard care for T2D patients, Smartwatch
No intervention, observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard care for T2D patients, Smartwatch
No intervention, observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affected by Type 2 Diabetes and monitored by Casa Sollievo della Sofferenza Hospital
* Basic skills in using a smartphone and its apps
* Available to use the device and its applications
* Ability to understand the informed consent
Exclusion Criteria
* Low life expectancy
* Type 1 Diabetes
* Secondary Diabetes
55 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Casa Sollievo della Sofferenza IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Salvatore De Cosmo, MD
Role: PRINCIPAL_INVESTIGATOR
Casa Sollievo della Sofferenza IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Casa Sollievo della Sofferenza IRCCS
San Giovanni Rotondo, FG, Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Copetti M, Shah H, Fontana A, Scarale MG, Menzaghi C, De Cosmo S, Garofolo M, Sorrentino MR, Lamacchia O, Penno G, Doria A, Trischitta V. Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4900-4908. doi: 10.1210/jc.2019-00215.
Related Links
Access external resources that provide additional context or updates about the study.
This study is currently in the frame of Horizon2020 GATEKEEPER project, that is a European Multi Centric Large-Scale Pilot on Smart Living Environments.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GATEKEEPER-V1.6_03 DIC 2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.